The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.
Summer Meeting 2017Join us in Harrogate 23rd to 26th July 2017
Antidepressants and SuicideProf Carmine Pariante attended House of Commons Health Select Committee regarding antidepressants and suicide
Metabolic Guidelines ArticleArticle on the recent metabolic guidelines by Peter Haddad, Gavin Reynolds and Stephen Cooper
Dementia Guidelines MeetingClinical Practice with Anti-Dementia Drugs: Updated Guidelines from the BAP, 19th January 2017
Fundamentals Wins BMA AwardFundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
Fundamentals of Clinical PsychopharmacologyBuy a discounted copy of the new Fundamentals of Clinical Psychopharmacology
Online CPD ResourceRCPsych Online CPD Subscribers get a discount on the BAP Online Resource
New world order: Brexit, drugs and researchLetter to House of Commons Science and Technology Committee
The Ten Secrets of Success in ScienceView Professor Trevor Robbins presenting his top tips
Neuroscience-based Nomenclature (NbN) for JoPJournal of Psychopharmacology chosen to trial new NbN
Benefits of BAP membership include:
- FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
- Reduced registration fees for the annual Summer Meeting.
- Half price subscription to the Online CPD Resource.
- Eligibility for prizes and awards.
- Student bursaries for the BAP Summer Meeting and international conferences.
- Reduced registration fees for selected partner association events.
- 50% OFF Royal Society of Biology membership (Read more)
- BAP Newsletter.
- Voting for BAP Officers and Council (full members only).
- Being part of one of the largest national psychopharmacology associations in the world.
|29th June 2017||Immune Function in Psychosis (iPSYCHOSIS)||National University of Ireland, University Rd, Galway|
|23rd July 2017||2017 Summer Meeting||Harrogate|
|20th August 2017||2017 ISN-ESN||Paris|
From Womb to Tomb: Stress Across a Lifetime
By Harry Potter
Posted on 5th June 2017
Stress. What does it mean to you? We probably all refer to it after a long or strenuous day at work, during a particularly heated family argument, or when thinking about our finances. But what does the word really mean, and why is it so important in our everyday lives? Can it increase our risk […]
Schizophrenia: From Lab Bench to Clinical Practice
By Peter Haddad
Posted on 1st June 2017
Pint of Science, Manchester, 15th May 2017 In mid-May BAP members Peter Haddad, Jo Neill and Lisa Heaney spoke in a city centre pub in Manchester in a lively and interactive public engagement session entitled ‘Schizophrenia: From Lab Bench to Clinical Practice’. The presentations highlighted the importance of translational preclinical work and how research findings […]
Antipsychotic medication and weight gain
By Peter Haddad
Posted on 31st March 2017
Introduction This article, written primarily for people with mental health problems and their carers, is about weight gain with antipsychotic medication. Antipsychotics are a group of drugs that are mainly used to treat schizophrenia and manic episodes in bipolar disorder. In both conditions, they are effective in treating symptoms and reducing the risk of a […]
A framework for a regulated market for cannabis in the UK: Recommendations from an expert panel
Professor Val Curran was interviewed by World at One on the release of the cannabis framework
12th May 2017
Psychiatry Moves to a New Beat With Novel Hip-Hop Program
Akeem and Becky (Hip Hop Psych) are interviewed by Medscape.
13th March 2017
Can we make cannabis safer?
Tom and co-author Amir talk to Editor Niall Boyce about cannabis harm reduction
1st March 2017
The Emotional Brain: The 14th Oxford Brain Day
Ciara speaks about her work on depression and antidepressants treatments for Oxford Brain Day
25th February 2017
Antidepressants may not be perfect, but they DO save lives
Carmine writes for the Daily Mail showing how, when used correctly, antidepressants do work
21st February 2017
|Bill Deakin to Receive 2017 BAP Lifetime Achievement Award |
14th June 2017
We are delighted to announce that the recipient of the 2017 BAP Lifetime Achievement Award is Professor Bill Deakin from Manchester.
|Perinatal Guidelines Meeting Now Open for Booking |
12th May 2017
Book your place on the Perinatal Guidelines Meeting
Book your place
|Perinatal Guidelines |
27th April 2017
The new Perinatal Guidelines are now online.
|Professor Carmine Pariante receives PNIRS Norman Cousins Award |
31st March 2017
Prof Carmine Pariante has received the prestigious Norman Cousins Award for outstanding contributions to research in psychoneuroimmunology
Most recent articles:
Journal of Psychopharmacology, Volume 31, Issue 6, Page 641-643, June 2017.
Journal of Psychopharmacology, Volume 31, Issue 6, Page 644-652, June 2017.
Journal of Psychopharmacology, Volume 31, Issue 6, Page 653-659, June 2017.
Psychopharmacology is the study of drugs that affect mood, behaviour and cognition. It aims to develop our understanding of the actions and effects of such drugs, which may include treatments for psychiatric disorders as well as substances that can be abused.